(Q40884603)

English

A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

9

object named as

Zhihang Peng

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

Yin Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Peng Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Ming Yue

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Jing Su

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Hongbo Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Mingzhu Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Jie Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Jun Li

8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Yun Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Rongbin Yu

11

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

3 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Journal of Human Genetics

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

301-305

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

https://scigraph.springernature.com/pub.10.1038/jhg.2015.145

0 references

Evolving epidemiology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Global epidemiology and genotype distribution of the hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Expert opinion on the treatment of patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Host genetic determinants in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

HLA class II associated with outcomes of hepatitis B and C infections

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Association of polymorphisms in HLA antigen presentation-related genes with the outcomes of HCV infection

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Alleles at rs4273729 in the chromosome 6 do not predict response to peg-interferon-α and ribavirin therapy in hepatitis C virus/HIV-1-coinfected patients

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Toward the establishment of a prediction system for the personalized treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.145

21 January 2018

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26632884

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26632884

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/JHG.2015.145

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40884603&oldid=1909567255"